303
Views
7
CrossRef citations to date
0
Altmetric
Reviews

MiRNA: a potential target for gene diagnosis and treatment of atherosclerotic stroke

, , , , , & show all
Pages 283-288 | Received 06 Dec 2018, Accepted 24 Feb 2020, Published online: 31 Mar 2020
 

Abstract

Stroke is one of the major diseases that endanger the physical health life of middle-aged and old people. It has the characteristics of high incidence, mortality and disability rate. Atherosclerosis is the main intervention target for stroke prevention and treatment. MiRNAs are highly expressed in the cerebral vasculature and play an important regulatory role in the pathogenesis of neuronal damage and ischemic stroke. This article reviews the mechanism of action between miRNAs and atherosclerosis, stroke, ischemia-reperfusion injury, collateral circulation and circRNA molecular networks, providing theoretical support for miRNA in gene diagnosis and drug therapy of atherosclerotic stroke.

Compliance with ethical standards

This is a review on miRNA and atherosclerotic stroke, no biological specimens used, no ethics involved. On behalf of all authors, the corresponding author states that there is no conflict of interest. The work described was original research that has not been published previously, and not under consideration for publication elsewhere, in whole or in part.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.